Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Canada
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Sciencearrow down
      < Back
    • Science
    • Areas of Focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Sustainabilityarrow down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • People
    • Governance
    • Charitable Contributions
  • Patients
  1. Home
  2. Leadership
  3. Walid Shammas

Walid Shammas

Back
Walid Shammas

Walid Shammas

  • Senior Director,
  • Medical and Regulatory Affairs
  • Follow in LinkedIn

Walid Shammas joined Ipsen Canada in 2021, bringing more than 20 years of experience both practicing as an MD and in progressive roles in the Canadian pharmaceutical industry. As Head of Medical and Regulatory Affairs, Walid will oversee development of medical and regulatory strategies and implementation of key activities related to all of our therapeutic indications for marketed and investigational products in Canada.

Before joining Ipsen, Walid served as VP Scientific Affairs at Purdue Canada as well as in leadership roles with Ferring Canada and Baxalta/Shire Canada. Earlier in his career he was a Medical Science Liaison and Clinical Research Associate.

Walid received his MD from Kaunas University of Medicine in Kaunas, Lithuania and was licensed by the USA Educational Commission for Foreign Medical Graduates (ECFMG).

IPN price

€103.00

 €-0.70 (-0.68%)

  • Investors
  • Partnering
  • Careers
  • Who We Are
  • Sustainability
  • Contact us

Canada
Linkedin Facebook Instagram Youtube
  • Terms of Use
  • Cookie Policy
  • Privacy Policy
  • Accessibility

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen Canada website. To continue, please click Continue.

Continue